Sterling Accuris acquires Gujarat Pathology Laboratory and Diagnostic Centre
Gujarat Pathology Lab consists of a network of 8 laboratories and more than 20 collection centres across Ahmedabad
Sterling Accuris Diagnostics announces the acquisition of Gujarat and Maha Gujarat Pathology Laboratories, a pathology service provider in Ahmedabad.
Sterling Accuris offers solutions to individual patients, hospitals, and corporates. This is the company’s fourth acquisition in the last two years. Through the acquisition of Gujarat Pathology Laboratory, Sterling Accuris aims to serve a larger patient base in Ahmedabad by leveraging its strengths in the B2C segment.
Gujarat Pathology Laboratory has been serving Ahmedabad since 1998 and offering a comprehensive range of diagnostic services in areas such as haematology, biochemistry, immunology and molecular biology. It consists of a network of 8 laboratories and more than 20 collection centres across Ahmedabad.
The diagnostic market in India is growing rapidly. According to recent research, the pathology segment is projected to grow at a CAGR of 14 per cent between 2025 and 2030.
Morgan Stanley Private Equity Asia is an investor in Sterling Accuris Wellness.
- Advertisement -